Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon acquired 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were bought at an average cost of GBX 1,767 ($22.00) per share, with a total value of £424.08 ($527.92).
Johnson Matthey Trading Down 0.9 %
Shares of Johnson Matthey stock traded down GBX 16 ($0.20) during midday trading on Thursday, reaching GBX 1,753 ($21.82). 354,391 shares of the company’s stock traded hands, compared to its average volume of 694,900. The company has a debt-to-equity ratio of 63.95, a quick ratio of 0.76 and a current ratio of 1.51. The company has a market cap of £3.22 billion, a PE ratio of 1,832.29, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.98. The stock has a 50 day moving average of GBX 1,699.10 and a 200-day moving average of GBX 1,624.93. Johnson Matthey PLC has a 12 month low of GBX 1,428.50 ($17.78) and a 12 month high of GBX 1,986.31 ($24.73).
Analyst Upgrades and Downgrades
JMAT has been the subject of a number of analyst reports. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,100 ($26.14) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. Berenberg Bank increased their price objective on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the company a “hold” rating in a research note on Monday, April 8th. Finally, Numis Securities reissued a “buy” rating and set a GBX 2,200 ($27.39) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,010 ($25.02).
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- With Risk Tolerance, One Size Does Not Fit All
- Comprehensive PepsiCo Stock Analysis
- How to invest in blue chip stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Bear Market Funds to Watch This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.